Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
162,8 USD | +0,12% | -2,98% | +5,05% |
30/04 | Alvotech gaat Humira Biosimilar Adalimumab-ryvk maken voor Quallent | MT |
29/04 | ABBVIE INC. : BMO Capital bevestigt koopadvies | ZM |
Officiële publicaties
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
1st quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
Proxy Statments | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 10K | CO | |
Annual results | CO | |
SEC Filing 13G | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO |
- Beurs
- Aandelen
- Koers ABBV
- Nieuws AbbVie Inc.
- Officiële publicaties